Coronary Artery Diseases Clinical Trial
Official title:
Clinical Trial Program of a Medical Instrument Product
This is a prospective, multi-center registry to evaluate safety and effectiveness of the Everolimus Drug Eluting Stent for treatment coronary revascularization in Chinese patients with long lesion, small vessel or multi-vessel diseases.
Study Device:The XIENCE V® Everolimus Eluting Coronary Stent System (XIENCE V EECSS or XIENCE V stent system) is a device/drug combination product consisting of either the MULTI-LINK VISION® Coronary Stent System or the MULTI-LINK MINI VISION® Coronary Stent System coated with a formulation containing everolimus, the active ingredient, embedded in a non-erodible polymer. Design:A prospective, multi-center, registry that is designed to enroll Chinese patients with either Long Lesion, or Small Vessel or Multi-Vessel diseases. Purpose:To evaluate the safety and effectiveness of the XIENCE V® everolimus drug eluting stent for coronary revascularization of patients with either long lesion, or small vessel, or multi-vessel diseases. Enrollment:Approximately 1900 patients will be enrolled in at least 45 but up to 51 centers. Mainland China 41 up to 47 centers, Taiwan China 3 centers and Macao China 1 center. This registry is planned to enroll at least 50% of patients with multi-vessel disease. Primary Endpoint:Ischemia-driven Target Vessel Failure (TVF) which is a composite of cardiac death, myocardial infarction (Q and non-Q wave) and target vessel revascularization (TVR) at 12 months post-index procedure. Follow-Up Visits:30 days, 6 months, 12 months, and 24 months post index procedure. ;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00328315 -
Cardiac SPECT With Rotating Slant Hole Collimator
|
||
| Recruiting |
NCT02257710 -
BIOFLOW-III UK Satellite Registry Orsiro Stent System
|
N/A | |
| Active, not recruiting |
NCT02273648 -
BIOTRONIK - BIOFLOW-III Registry French Satellite
|
N/A | |
| Completed |
NCT02028728 -
BIOFLOW III Satellite-Italy Orsiro Stent System
|
N/A | |
| Completed |
NCT02813473 -
SYNTAX III REVOLUTION Trial: A Randomized Study Investigating the Use of CT Scan and Angiography of the Heart to Help the Doctors Decide Which Method is the Best to Improve Blood Supply to the Heart in Patients With Complex Coronary Artery Disease
|
||
| Completed |
NCT05853250 -
Clinical and Hospital Stay Effects of Reiki and Manual Therapy After Open Heart Surgery
|
N/A | |
| Recruiting |
NCT02635230 -
What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
|
||
| Completed |
NCT01116882 -
Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings
|
N/A | |
| Completed |
NCT00920283 -
COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent
|
N/A | |
| Completed |
NCT01700075 -
Physical and Chemical Study of Atherosclerosis Mechanisms
|
Phase 4 | |
| Completed |
NCT00607217 -
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases
|
Phase 2/Phase 3 | |
| Completed |
NCT00607178 -
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT05486780 -
The Effect of Digital Window on Day and Night Perception Status and Sleep Quality in Intensive Care Patients
|
N/A | |
| Terminated |
NCT01665248 -
Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina
|
N/A | |
| Terminated |
NCT01612819 -
DXR Stent(Previous Cilotax) Implantation Registry
|
N/A | |
| Active, not recruiting |
NCT01226355 -
NOYA CoCr Biodegradable Coating Sirolimus-Eluting Coronary Stent System
|
N/A | |
| Recruiting |
NCT02247492 -
BIOFLOW-III VIP Russia Registry Orsiro Stent System
|